Status:
RECRUITING
Impact of COVID-19 on Quality of Life of Seniors With Eye Disease and Implementations to Improve Wellness
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Covid19
Eye Diseases
Eligibility:
All Genders
65+ years
Brief Summary
The ophthalmology clientele is vulnerable in the context of the coronavirus disease 2019 (COVID-19) pandemic because of their age and comorbidities. Specifically, elderly patients aged 65 and above wi...
Detailed Description
BACKGROUND AND RATIONALE COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Like many healthcare departments, the department ophthalmology presents risk of COVID-...
Eligibility Criteria
Inclusion
- Patients diagnosed with an eye disease by an experienced ophthalmologist.
- Patients with eye diseases age 65 and above.
- Be able to provide valid informed consent to participate in the research study.
- Being able to read and understand English.
- Having no significant self-reported or a physician diagnosed mental health disorder.
Exclusion
- Inability to provide a valid informed consent.
- Significant communication barriers or lack of English proficiency that prevents participants from completing the questionnaires.
- Severe depression as confirmed by a CES-D ≥ 24.
- Having a lifetime diagnosis of self-reported other serious mental disorders, including bipolar I or II disorder, primary psychotic disorder (schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder).
- Self-reported substance abuse or dependence within the past 3 months.
- Having an acutely unstable medical illnesses, including delirium or acute cerebrovascular or cardiovascular events within the last 6 months.
- Having irreversible vision loss that prevents one from completing the questionnaires.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
425 Patients enrolled
Trial Details
Trial ID
NCT04910282
Start Date
January 1 2023
End Date
December 31 2024
Last Update
February 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Hospital
London, Ontario, Canada, N6A4V2